1074 related articles for article (PubMed ID: 17342035)
1. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
[TBL] [Abstract][Full Text] [Related]
2. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
3. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
4. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis.
Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Nekolla S; Vogt W; Schwaiger M; Schömig A; Kastrati A
Am J Cardiol; 2006 Apr; 97(8):1151-6. PubMed ID: 16616017
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
[TBL] [Abstract][Full Text] [Related]
8. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides.
Foote RS; Pearlman JD; Siegel AH; Yeo KT
J Am Coll Cardiol; 2004 Nov; 44(10):1980-7. PubMed ID: 15542280
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
He PC; Duan CY; Liu YH; Wei XB; Lin SG
BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with spect perfusion imaging.
Zaid G; Tanchilevitch A; Rivlin E; Gropper R; Rosenschein U; Lanir A; Goldhammer E
Int J Cardiol; 2007 Apr; 117(2):157-64. PubMed ID: 16997398
[TBL] [Abstract][Full Text] [Related]
11. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function.
Mayr A; Mair J; Schocke M; Klug G; Pedarnig K; Haubner BJ; Nowosielski M; Grubinger T; Pachinger O; Metzler B
Int J Cardiol; 2011 Feb; 147(1):118-23. PubMed ID: 19896736
[TBL] [Abstract][Full Text] [Related]
13. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.
Sabatine MS; Morrow DA; de Lemos JA; Omland T; Desai MY; Tanasijevic M; Hall C; McCabe CH; Braunwald E
J Am Coll Cardiol; 2004 Nov; 44(10):1988-95. PubMed ID: 15542281
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.
Bibbins-Domingo K; Ansari M; Schiller NB; Massie B; Whooley MA
Circulation; 2003 Dec; 108(24):2987-92. PubMed ID: 14662720
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
16. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
[TBL] [Abstract][Full Text] [Related]
17. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.
Vanzetto G; Jacon P; Calizzano A; Neuder Y; Faure P; Fagret D; Machecourt J
J Nucl Cardiol; 2007; 14(6):835-42. PubMed ID: 18022110
[TBL] [Abstract][Full Text] [Related]
19. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
